Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 960-964

  Giannantoni, Antonella ^a   Conte, Antonella ^b   Proietti, Silvia ^a   Giovannozzi, Silvia ^a   Rossi, Aroldo ^a   Fabbrini, Giovanni ^b   Porena, Massimo ^a   Berardelli, Alfredo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

botulinum toxin type A; neurogenic; overactive; Parkinson disease; quality of life; urinary bladder

Indexed keywords

BOTULINUM TOXIN A;

AGED; ARTICLE; BLADDER PRESSURE; CLINICAL ARTICLE; CYSTOMETRY; DAILY LIFE ACTIVITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; OVERACTIVE BLADDER; PARKINSON DISEASE; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; URINARY FREQUENCY; URINE INCONTINENCE; URODYNAMICS; VISUAL ANALOG SCALE;

AGED; BOTULINUM TOXINS, TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROMUSCULAR AGENTS; PARKINSON DISEASE; TIME FACTORS; URINARY BLADDER, OVERACTIVE;

EID: 80051544250     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.071     Document Type: Article

References (23)

1. K. Winge, and C.J. Fowler Bladder dysfunction in Parkinsonism: mechanism, prevalence, symptoms and management Mov Disord 21 2006 737
2. C.J. Fowler Update of the neurology of Parkinson's disease Neurourol Urodyn 26 2007 103
3. S.M. Di Stasi, A. Giannantoni, and G. Vespasiani Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens J Urol 165 2001 491
4. A. Giannantoni, A. Rossi, and E. Mearini Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy J Urol 182 2009 1453
5. H. Kulaksizoglu, and Y. Parman Use of botulinum toxin-A for the treatment of overactive bladder symptoms in patients with Parkinson's disease Parkinsonism Relat Disord 16 2010 531
6. A.J. Hughes, S.E. Daniel, and L. Kilford Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181
7. T.H. Wagner, D.L. Patrick, and T.G. Bavendam Quality of life of persons with urinary incontinence: development of a new measure Urology 47 1996 67
8. E.S. Lukacz, E.L. Whitcomb, and J.M. Lawrence Are sexual activity and satisfaction affected by pelvic floor disorders? Analysis of a community-based survey Am J Obstet Gynecol 197 2007 88
9. M. Stöhrer, M. Goepel, and A. Kondo The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures International Continence Society Standardization Committee Neurourol Urodyn 18 1999 139
10. B. Schurch, M. Stöhrer, and G. Kramer Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 2000 692
11. U. Mehnert, J. Birzele, and K. Reuter The effect of botulinum toxin type A on overactive bladder symptoms in patients with multiple sclerosis: a pilot study J Urol 184 2010 1011
12. M.K. Flynn, C.L. Amundsen, and M. Perevich Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder J Urol 181 2009 2608
13. A. Sahai, C. Dowson, and M.S. Khan Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial BJU Int 103 2009 1509
14. G. Schiavo, O. Rossetto, and F. Benfenati Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus Ann NY Acad Sci 710 1994 65
15. J.A. Hamjian, and F.O. Walker Serial neurophysiological studies of intramuscular botulinum-A toxin in humans Muscle Nerve 17 1994 1385
16. R.L. Rosales, and D. Dressler On muscle spindles, dystonia and botulinum toxin Eur J Neurol 17 2010 71
17. A. Curr, and A. Berardelli Do the unintended actions of botulinum toxin at distant sites have clinical implications? Neurology 72 2009 1095
18. C. Trompetto, A. Curr, and A. Buccolieri Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex Mov Disord 21 2006 777
19. C. Trompetto, M. Bove, and L. Avanzino Intrafusal effects of botulinum toxin in post-stroke upper limb spasticity Eur J Neurol 15 2008 367
20. G. Abbruzzese, and A. Berardelli Neurophysiological effects of botulinum toxin type A Neurotox Res 9 2006 109
21. A. Haferkamp, B. Schurch, and A. Reitz Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder Eur Urol 46 2004 784
22. A. Apostolidis, P. Dasgupta, and C.J. Fowler Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 2006 644
23. A. Giannantoni, S.M. Di Stasi, and V. Nardicchi Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity J Urol 175 2006 2341